Gilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 19, 2022
Big Health
|
Series C | $75M | Health Care | — |
Jan 11, 2022
ProVerum Medical
|
Series A | €30M | Health Care | Yes |
Mar 17, 2021
Amphista Therapeutics
|
Series B | $53M | Biopharma | Yes |
Jul 29, 2020
Eargo
|
Series E | $81.57M | Audio | Yes |
Jul 28, 2020
Withings
|
Series B | $60M | Apps | Yes |